Structure

Physi-Chem Properties

Molecular Weight:  456.32
Volume:  494.609
LogP:  5.321
LogD:  4.889
LogS:  -5.575
# Rotatable Bonds:  3
TPSA:  52.6
# H-Bond Aceptor:  4
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.447
Synthetic Accessibility Score:  4.743
Fsp3:  0.862
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.109
MDCK Permeability:  6.0796464822487906e-05
Pgp-inhibitor:  0.978
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.965
30% Bioavailability (F30%):  0.832

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.042
Plasma Protein Binding (PPB):  95.35277557373047%
Volume Distribution (VD):  1.399
Pgp-substrate:  2.6671786308288574%

ADMET: Metabolism

CYP1A2-inhibitor:  0.069
CYP1A2-substrate:  0.203
CYP2C19-inhibitor:  0.296
CYP2C19-substrate:  0.926
CYP2C9-inhibitor:  0.265
CYP2C9-substrate:  0.237
CYP2D6-inhibitor:  0.478
CYP2D6-substrate:  0.177
CYP3A4-inhibitor:  0.652
CYP3A4-substrate:  0.574

ADMET: Excretion

Clearance (CL):  3.158
Half-life (T1/2):  0.254

ADMET: Toxicity

hERG Blockers:  0.177
Human Hepatotoxicity (H-HT):  0.405
Drug-inuced Liver Injury (DILI):  0.032
AMES Toxicity:  0.002
Rat Oral Acute Toxicity:  0.052
Maximum Recommended Daily Dose:  0.911
Skin Sensitization:  0.965
Carcinogencity:  0.011
Eye Corrosion:  0.954
Eye Irritation:  0.889
Respiratory Toxicity:  0.962

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC302280

Natural Product ID:  NPC302280
Common Name*:   Aglaiabbreviatin B
IUPAC Name:   [(3R,5R,8R,9R,10R,13R,14R,17S)-4,4,8,10,14-pentamethyl-17-[(2S)-2-methyl-5-oxofuran-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
Synonyms:   Aglaiabbreviatin B
Standard InCHIKey:  QTFVCZBNOHEKLA-LKJFLBAOSA-N
Standard InCHI:  InChI=1S/C29H44O4/c1-18(30)32-23-12-14-26(4)21(25(23,2)3)11-16-28(6)22(26)9-8-19-20(10-15-27(19,28)5)29(7)17-13-24(31)33-29/h13,17,19-23H,8-12,14-16H2,1-7H3/t19-,20+,21+,22-,23-,26+,27-,28-,29+/m1/s1
SMILES:  CC(=O)O[C@@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2CC[C@H]2[C@@]1(C)CC[C@@H]2[C@]1(C)C=CC(=O)O1)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1651321
PubChem CID:   50908215
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7602 Aglaia abbreviata Species Meliaceae Eukaryota n.a. stem n.a. PMID[21087017]
NPO7602 Aglaia abbreviata Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[21087017]
NPO7602 Aglaia abbreviata Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens IC50 > 10000.0 nM PMID[558460]
NPT91 Cell Line KB Homo sapiens IC50 > 10000.0 nM PMID[558460]
NPT659 Cell Line SMMC-7721 Homo sapiens IC50 > 10000.0 nM PMID[558460]
NPT111 Cell Line K562 Homo sapiens IC50 > 10000.0 nM PMID[558460]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[558460]
NPT2 Others Unspecified IC50 > 10000 nM PMID[21087017]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC302280 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9432 High Similarity NPC201725
0.8953 High Similarity NPC474013
0.8646 High Similarity NPC112009
0.8646 High Similarity NPC180204
0.8632 High Similarity NPC25177
0.8632 High Similarity NPC222875
0.8632 High Similarity NPC295110
0.8632 High Similarity NPC247701
0.8632 High Similarity NPC268829
0.8556 High Similarity NPC177141
0.8556 High Similarity NPC285982
0.8526 High Similarity NPC201406
0.8511 High Similarity NPC231751
0.8454 Intermediate Similarity NPC189588
0.8454 Intermediate Similarity NPC10232
0.8454 Intermediate Similarity NPC196471
0.8454 Intermediate Similarity NPC187302
0.8454 Intermediate Similarity NPC160583
0.8454 Intermediate Similarity NPC97487
0.8444 Intermediate Similarity NPC93411
0.8409 Intermediate Similarity NPC96055
0.837 Intermediate Similarity NPC329842
0.837 Intermediate Similarity NPC177641
0.8367 Intermediate Similarity NPC165969
0.8283 Intermediate Similarity NPC220217
0.8283 Intermediate Similarity NPC186668
0.8283 Intermediate Similarity NPC119855
0.828 Intermediate Similarity NPC38232
0.8265 Intermediate Similarity NPC171014
0.8265 Intermediate Similarity NPC472821
0.8265 Intermediate Similarity NPC297617
0.8261 Intermediate Similarity NPC273199
0.8242 Intermediate Similarity NPC473879
0.8242 Intermediate Similarity NPC106332
0.8229 Intermediate Similarity NPC218107
0.82 Intermediate Similarity NPC43063
0.82 Intermediate Similarity NPC79298
0.8182 Intermediate Similarity NPC189616
0.8182 Intermediate Similarity NPC471218
0.8152 Intermediate Similarity NPC82876
0.8144 Intermediate Similarity NPC472826
0.8125 Intermediate Similarity NPC38530
0.8125 Intermediate Similarity NPC84335
0.8125 Intermediate Similarity NPC2049
0.8105 Intermediate Similarity NPC474909
0.8105 Intermediate Similarity NPC281134
0.8105 Intermediate Similarity NPC33473
0.81 Intermediate Similarity NPC295843
0.809 Intermediate Similarity NPC139206
0.809 Intermediate Similarity NPC470558
0.809 Intermediate Similarity NPC30502
0.8085 Intermediate Similarity NPC7349
0.8085 Intermediate Similarity NPC476304
0.8065 Intermediate Similarity NPC78973
0.8061 Intermediate Similarity NPC168319
0.8061 Intermediate Similarity NPC194028
0.8041 Intermediate Similarity NPC252295
0.8039 Intermediate Similarity NPC75389
0.8039 Intermediate Similarity NPC475030
0.8022 Intermediate Similarity NPC286153
0.8022 Intermediate Similarity NPC131813
0.8021 Intermediate Similarity NPC194132
0.8021 Intermediate Similarity NPC209297
0.8021 Intermediate Similarity NPC475380
0.8021 Intermediate Similarity NPC307164
0.8 Intermediate Similarity NPC476186
0.8 Intermediate Similarity NPC105490
0.8 Intermediate Similarity NPC140277
0.8 Intermediate Similarity NPC318515
0.7979 Intermediate Similarity NPC110923
0.7979 Intermediate Similarity NPC74296
0.7961 Intermediate Similarity NPC16270
0.7961 Intermediate Similarity NPC103491
0.7959 Intermediate Similarity NPC251680
0.7959 Intermediate Similarity NPC470906
0.7957 Intermediate Similarity NPC262858
0.7957 Intermediate Similarity NPC472240
0.7941 Intermediate Similarity NPC275060
0.7941 Intermediate Similarity NPC304276
0.7941 Intermediate Similarity NPC137462
0.7938 Intermediate Similarity NPC311241
0.7938 Intermediate Similarity NPC110937
0.7938 Intermediate Similarity NPC475446
0.7938 Intermediate Similarity NPC51499
0.7938 Intermediate Similarity NPC210337
0.7935 Intermediate Similarity NPC166857
0.7921 Intermediate Similarity NPC472818
0.7917 Intermediate Similarity NPC84383
0.7917 Intermediate Similarity NPC276110
0.7895 Intermediate Similarity NPC205034
0.7895 Intermediate Similarity NPC162615
0.7895 Intermediate Similarity NPC152778
0.7889 Intermediate Similarity NPC476927
0.7872 Intermediate Similarity NPC8062
0.7872 Intermediate Similarity NPC161638
0.7872 Intermediate Similarity NPC474842
0.7872 Intermediate Similarity NPC310479
0.7872 Intermediate Similarity NPC475965
0.7865 Intermediate Similarity NPC170303
0.7857 Intermediate Similarity NPC108368
0.7857 Intermediate Similarity NPC98868
0.7857 Intermediate Similarity NPC107806
0.7857 Intermediate Similarity NPC57079
0.7857 Intermediate Similarity NPC275086
0.7857 Intermediate Similarity NPC92275
0.7857 Intermediate Similarity NPC72647
0.7857 Intermediate Similarity NPC325229
0.7843 Intermediate Similarity NPC472820
0.7841 Intermediate Similarity NPC153987
0.7841 Intermediate Similarity NPC44083
0.7835 Intermediate Similarity NPC114743
0.7835 Intermediate Similarity NPC88009
0.7835 Intermediate Similarity NPC195366
0.7835 Intermediate Similarity NPC16967
0.7835 Intermediate Similarity NPC190713
0.7826 Intermediate Similarity NPC474970
0.7822 Intermediate Similarity NPC472819
0.7816 Intermediate Similarity NPC189206
0.7812 Intermediate Similarity NPC471994
0.7812 Intermediate Similarity NPC166143
0.7812 Intermediate Similarity NPC84893
0.7812 Intermediate Similarity NPC119562
0.7812 Intermediate Similarity NPC279410
0.7812 Intermediate Similarity NPC120351
0.781 Intermediate Similarity NPC214005
0.781 Intermediate Similarity NPC150228
0.781 Intermediate Similarity NPC470063
0.781 Intermediate Similarity NPC44537
0.7802 Intermediate Similarity NPC470077
0.7802 Intermediate Similarity NPC306951
0.7789 Intermediate Similarity NPC234335
0.7788 Intermediate Similarity NPC12795
0.7778 Intermediate Similarity NPC230546
0.7778 Intermediate Similarity NPC256112
0.7778 Intermediate Similarity NPC473510
0.7778 Intermediate Similarity NPC471413
0.7778 Intermediate Similarity NPC476303
0.7766 Intermediate Similarity NPC146554
0.7766 Intermediate Similarity NPC288699
0.7766 Intermediate Similarity NPC170633
0.7755 Intermediate Similarity NPC10057
0.7755 Intermediate Similarity NPC99726
0.7755 Intermediate Similarity NPC100912
0.7755 Intermediate Similarity NPC292133
0.7755 Intermediate Similarity NPC141401
0.7755 Intermediate Similarity NPC253826
0.7753 Intermediate Similarity NPC304194
0.7753 Intermediate Similarity NPC269791
0.7753 Intermediate Similarity NPC469802
0.7753 Intermediate Similarity NPC206735
0.7745 Intermediate Similarity NPC266570
0.7745 Intermediate Similarity NPC189863
0.7742 Intermediate Similarity NPC264546
0.7742 Intermediate Similarity NPC478104
0.7736 Intermediate Similarity NPC171126
0.7732 Intermediate Similarity NPC472441
0.7727 Intermediate Similarity NPC184737
0.7727 Intermediate Similarity NPC105197
0.7723 Intermediate Similarity NPC473283
0.7723 Intermediate Similarity NPC176883
0.7723 Intermediate Similarity NPC476237
0.7723 Intermediate Similarity NPC475526
0.7723 Intermediate Similarity NPC329345
0.7723 Intermediate Similarity NPC45897
0.7717 Intermediate Similarity NPC475860
0.7717 Intermediate Similarity NPC474694
0.7717 Intermediate Similarity NPC472442
0.7717 Intermediate Similarity NPC22133
0.7717 Intermediate Similarity NPC473659
0.7714 Intermediate Similarity NPC470076
0.7714 Intermediate Similarity NPC183603
0.7708 Intermediate Similarity NPC214697
0.7708 Intermediate Similarity NPC79117
0.7708 Intermediate Similarity NPC472871
0.7708 Intermediate Similarity NPC139692
0.7708 Intermediate Similarity NPC53555
0.7708 Intermediate Similarity NPC474185
0.77 Intermediate Similarity NPC310981
0.77 Intermediate Similarity NPC11974
0.77 Intermediate Similarity NPC471412
0.7684 Intermediate Similarity NPC280149
0.7684 Intermediate Similarity NPC221111
0.7684 Intermediate Similarity NPC182136
0.7677 Intermediate Similarity NPC181147
0.7677 Intermediate Similarity NPC278673
0.767 Intermediate Similarity NPC255387
0.767 Intermediate Similarity NPC475294
0.767 Intermediate Similarity NPC131665
0.7667 Intermediate Similarity NPC25554
0.7664 Intermediate Similarity NPC471633
0.7664 Intermediate Similarity NPC84949
0.7664 Intermediate Similarity NPC69576
0.7664 Intermediate Similarity NPC31354
0.766 Intermediate Similarity NPC226863
0.7653 Intermediate Similarity NPC473153
0.7653 Intermediate Similarity NPC260796
0.7653 Intermediate Similarity NPC471903
0.7642 Intermediate Similarity NPC69291
0.7642 Intermediate Similarity NPC247760
0.764 Intermediate Similarity NPC47808

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC302280 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8041 Intermediate Similarity NPD7638 Approved
0.7959 Intermediate Similarity NPD7640 Approved
0.7959 Intermediate Similarity NPD7639 Approved
0.7957 Intermediate Similarity NPD6051 Approved
0.7582 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD7327 Approved
0.7455 Intermediate Similarity NPD7328 Approved
0.7451 Intermediate Similarity NPD7632 Discontinued
0.7387 Intermediate Similarity NPD7516 Approved
0.7374 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7364 Intermediate Similarity NPD7115 Discovery
0.7363 Intermediate Similarity NPD7525 Registered
0.734 Intermediate Similarity NPD1694 Approved
0.7321 Intermediate Similarity NPD8294 Approved
0.7321 Intermediate Similarity NPD8377 Approved
0.7292 Intermediate Similarity NPD6672 Approved
0.7292 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6903 Approved
0.7292 Intermediate Similarity NPD5737 Approved
0.7264 Intermediate Similarity NPD6881 Approved
0.7264 Intermediate Similarity NPD6899 Approved
0.7263 Intermediate Similarity NPD6409 Approved
0.7263 Intermediate Similarity NPD5330 Approved
0.7263 Intermediate Similarity NPD6684 Approved
0.7263 Intermediate Similarity NPD7334 Approved
0.7263 Intermediate Similarity NPD7521 Approved
0.7263 Intermediate Similarity NPD7146 Approved
0.7257 Intermediate Similarity NPD8379 Approved
0.7257 Intermediate Similarity NPD8296 Approved
0.7257 Intermediate Similarity NPD8378 Approved
0.7257 Intermediate Similarity NPD8380 Approved
0.7257 Intermediate Similarity NPD8335 Approved
0.7257 Intermediate Similarity NPD8033 Approved
0.7245 Intermediate Similarity NPD5693 Phase 1
0.717 Intermediate Similarity NPD5697 Approved
0.7157 Intermediate Similarity NPD4225 Approved
0.713 Intermediate Similarity NPD6883 Approved
0.713 Intermediate Similarity NPD7290 Approved
0.713 Intermediate Similarity NPD7102 Approved
0.7103 Intermediate Similarity NPD6011 Approved
0.7103 Intermediate Similarity NPD7320 Approved
0.71 Intermediate Similarity NPD7748 Approved
0.71 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.71 Intermediate Similarity NPD7900 Approved
0.7075 Intermediate Similarity NPD6675 Approved
0.7075 Intermediate Similarity NPD6402 Approved
0.7075 Intermediate Similarity NPD7128 Approved
0.7075 Intermediate Similarity NPD5739 Approved
0.7075 Intermediate Similarity NPD6008 Approved
0.7071 Intermediate Similarity NPD6079 Approved
0.7064 Intermediate Similarity NPD6649 Approved
0.7064 Intermediate Similarity NPD8130 Phase 1
0.7064 Intermediate Similarity NPD6847 Approved
0.7064 Intermediate Similarity NPD6617 Approved
0.7064 Intermediate Similarity NPD6650 Approved
0.7064 Intermediate Similarity NPD6869 Approved
0.7041 Intermediate Similarity NPD6673 Approved
0.7041 Intermediate Similarity NPD6904 Approved
0.7041 Intermediate Similarity NPD6080 Approved
0.7037 Intermediate Similarity NPD6013 Approved
0.7037 Intermediate Similarity NPD6012 Approved
0.7037 Intermediate Similarity NPD6014 Approved
0.701 Intermediate Similarity NPD3573 Approved
0.7009 Intermediate Similarity NPD7507 Approved
0.7 Intermediate Similarity NPD6882 Approved
0.7 Intermediate Similarity NPD8297 Approved
0.7 Intermediate Similarity NPD6399 Phase 3
0.6957 Remote Similarity NPD7503 Approved
0.6931 Remote Similarity NPD6001 Approved
0.69 Remote Similarity NPD8034 Phase 2
0.69 Remote Similarity NPD7515 Phase 2
0.69 Remote Similarity NPD8035 Phase 2
0.6893 Remote Similarity NPD7902 Approved
0.6893 Remote Similarity NPD6083 Phase 2
0.6893 Remote Similarity NPD6084 Phase 2
0.6882 Remote Similarity NPD4195 Approved
0.6881 Remote Similarity NPD6372 Approved
0.6881 Remote Similarity NPD6373 Approved
0.6869 Remote Similarity NPD5328 Approved
0.6852 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6852 Remote Similarity NPD5701 Approved
0.6833 Remote Similarity NPD7319 Approved
0.6804 Remote Similarity NPD7520 Clinical (unspecified phase)
0.68 Remote Similarity NPD5207 Approved
0.6796 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6796 Remote Similarity NPD5222 Approved
0.6796 Remote Similarity NPD5221 Approved
0.6792 Remote Similarity NPD5211 Phase 2
0.6768 Remote Similarity NPD5208 Approved
0.6762 Remote Similarity NPD5286 Approved
0.6762 Remote Similarity NPD5285 Approved
0.6762 Remote Similarity NPD4696 Approved
0.6757 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6735 Remote Similarity NPD3618 Phase 1
0.6735 Remote Similarity NPD6098 Approved
0.6733 Remote Similarity NPD5694 Approved
0.6733 Remote Similarity NPD6050 Approved
0.6731 Remote Similarity NPD5173 Approved
0.6727 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6699 Remote Similarity NPD5695 Phase 3
0.6698 Remote Similarity NPD5223 Approved
0.6696 Remote Similarity NPD6335 Approved
0.6667 Remote Similarity NPD4202 Approved
0.6667 Remote Similarity NPD6868 Approved
0.6667 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5141 Approved
0.6667 Remote Similarity NPD5696 Approved
0.6638 Remote Similarity NPD7101 Approved
0.6638 Remote Similarity NPD7100 Approved
0.6637 Remote Similarity NPD4632 Approved
0.6636 Remote Similarity NPD4633 Approved
0.6636 Remote Similarity NPD6686 Approved
0.6636 Remote Similarity NPD5224 Approved
0.6636 Remote Similarity NPD5226 Approved
0.6636 Remote Similarity NPD5225 Approved
0.6634 Remote Similarity NPD5692 Phase 3
0.663 Remote Similarity NPD7339 Approved
0.663 Remote Similarity NPD6942 Approved
0.6609 Remote Similarity NPD6317 Approved
0.6604 Remote Similarity NPD6648 Approved
0.6574 Remote Similarity NPD5174 Approved
0.6574 Remote Similarity NPD5175 Approved
0.6571 Remote Similarity NPD4755 Approved
0.6569 Remote Similarity NPD7637 Suspended
0.6566 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6559 Remote Similarity NPD6117 Approved
0.6552 Remote Similarity NPD6313 Approved
0.6552 Remote Similarity NPD6314 Approved
0.6542 Remote Similarity NPD5344 Discontinued
0.6531 Remote Similarity NPD4786 Approved
0.6526 Remote Similarity NPD7645 Phase 2
0.6525 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6522 Remote Similarity NPD6274 Approved
0.65 Remote Similarity NPD7492 Approved
0.6489 Remote Similarity NPD6116 Phase 1
0.6476 Remote Similarity NPD4697 Phase 3
0.6475 Remote Similarity NPD7736 Approved
0.6471 Remote Similarity NPD5785 Approved
0.6466 Remote Similarity NPD6009 Approved
0.6449 Remote Similarity NPD4700 Approved
0.6446 Remote Similarity NPD6616 Approved
0.6441 Remote Similarity NPD6054 Approved
0.6441 Remote Similarity NPD6319 Approved
0.6429 Remote Similarity NPD6695 Phase 3
0.6422 Remote Similarity NPD6052 Approved
0.6421 Remote Similarity NPD6115 Approved
0.6421 Remote Similarity NPD6697 Approved
0.6421 Remote Similarity NPD6118 Approved
0.6421 Remote Similarity NPD6114 Approved
0.6417 Remote Similarity NPD7604 Phase 2
0.6408 Remote Similarity NPD5284 Approved
0.6408 Remote Similarity NPD5281 Approved
0.6404 Remote Similarity NPD6053 Discontinued
0.6396 Remote Similarity NPD6614 Approved
0.6393 Remote Similarity NPD7078 Approved
0.6387 Remote Similarity NPD5983 Phase 2
0.6383 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6381 Remote Similarity NPD4629 Approved
0.6381 Remote Similarity NPD5210 Approved
0.6381 Remote Similarity NPD5654 Approved
0.6373 Remote Similarity NPD4753 Phase 2
0.6364 Remote Similarity NPD6400 Clinical (unspecified phase)
0.6364 Remote Similarity NPD2685 Clinical (unspecified phase)
0.6364 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6364 Remote Similarity NPD3133 Approved
0.6364 Remote Similarity NPD3666 Approved
0.6364 Remote Similarity NPD3668 Phase 3
0.6364 Remote Similarity NPD3665 Phase 1
0.6355 Remote Similarity NPD5290 Discontinued
0.6344 Remote Similarity NPD4784 Approved
0.6344 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6344 Remote Similarity NPD6926 Approved
0.6344 Remote Similarity NPD6924 Approved
0.6344 Remote Similarity NPD4785 Approved
0.6339 Remote Similarity NPD4730 Approved
0.6339 Remote Similarity NPD4729 Approved
0.6337 Remote Similarity NPD4751 Clinical (unspecified phase)
0.6333 Remote Similarity NPD6370 Approved
0.6327 Remote Similarity NPD5209 Approved
0.6327 Remote Similarity NPD3667 Approved
0.6327 Remote Similarity NPD4221 Approved
0.6327 Remote Similarity NPD4223 Phase 3
0.6311 Remote Similarity NPD6336 Discontinued
0.6304 Remote Similarity NPD5777 Approved
0.6304 Remote Similarity NPD4243 Approved
0.63 Remote Similarity NPD5329 Approved
0.63 Remote Similarity NPD6082 Clinical (unspecified phase)
0.6273 Remote Similarity NPD4754 Approved
0.6264 Remote Similarity NPD4267 Clinical (unspecified phase)
0.6263 Remote Similarity NPD4788 Approved
0.6262 Remote Similarity NPD5959 Approved
0.625 Remote Similarity NPD6016 Approved
0.625 Remote Similarity NPD5784 Clinical (unspecified phase)
0.625 Remote Similarity NPD6909 Approved
0.625 Remote Similarity NPD6908 Approved
0.625 Remote Similarity NPD6015 Approved
0.6238 Remote Similarity NPD5690 Phase 2
0.6228 Remote Similarity NPD5135 Approved
0.6228 Remote Similarity NPD5251 Approved
0.6228 Remote Similarity NPD5134 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data